Stratus Therapeutics
Allie Gallion has a diverse range of work experience in the bioscience field. Allie'smost recent role was as an Associate Scientist at Garuda Therapeutics, starting in 2023. Prior to that, they worked as a Research Associate II at Q-State Biosciences from 2022 to 2023. In 2021, they worked as a Biological Lab Technician Co-op at Wentworth Institute of Technology. Before that, they held the position of Student Intern at New England Biolabs from 2018 to 2020. Allie also completed a UNH Summer Externship at UNH College of Life Sciences and Agriculture in 2017.
Allie Gallion attended the Wentworth Institute of Technology from 2018 to 2022 where they earned a Bachelor's degree in Biological/Biosystems Engineering.
This person is not in any offices
Stratus Therapeutics
4 followers
Stratus Therapeutics is redefining regenerative medicine with Stratus Prime™ — a platform for full hematopoietic system renewal, on demand. Our proprietary product, ST-101, includes both hematopoietic stem cells (Prime HSCs™) and hematopoietic progenitor cells (Prime HPCs™) to drive durable, long-term engraftment with full hematopoietic system restoration, while supporting near-term immune reconstitution.